Oxycodone - Pain
You are here : Home > Formulary Search > Oxycodone - Pain
Status 1
- Capsules
- Oral solution
Status 2
- Modified release tablets
Status 3
- Injection
Documentation
PAD Profile
Other Indications
Below are listed other indications that Oxycodone is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Pain .
- Alfentanil hydrochloride
- Aspirin
- Buprenorphine
- Cannabis (medicinal)
- Co-codamol
- Co-dydramol 10/500
- Co-dydramol 20/500
- Co-dydramol 30/500
- Co-proxamol (Dextropropoxyphene hydrochloride/para
- Codeine phosphate
- Diamorphine hydrochloride
- Dihydrocodeine tartrate
- Fentanyl
- Gabapentin
- Ibuprofen
- Ketamine
- Meptazinol hydrochloride
- Methoxyflurane
- Morphine sulfate
- Nefopam hydrochloride
- Oxycodone with naloxone
- Paracetamol
- Pethidine hydrochloride
- Pregabalin
- Sufentanil
- Tramadol hydrochloride
- Tramadol with Dexketoprofen
- Tramadol with paracetamol
- Ziconotide acetate
Committee Recommendations (4)
The Surrey Heartlands preferred brands of oxycodone are:
Longtec (oxycodone modified release)
Shortec (oxycodone immediate release)
The North West Surrey MOG, in agreement with ASPH, have aligned their preferred brands of oxycodone with the rest of Surrey Heartlands and now recommend Longtec / Shortec.
There is no requirement so switch patients who are currently receiving other brands.
A stepped approach to pain management is recommended. A trial of oxycodone may be appropriate if the patient is intolerant to morphine. (Take into consideration dose equivalence - oxycodone is twice as potent as morphine so dose should be adjusted accordingly). See guidelines below for further information.
Ensure a patient agreement is completed by the patient (see below) prior to a trial of Oxycodone
Note the recommendations made at the Prescribing Clinical Network in December 2016 (below) in relation to brand prescribing.
Patients currently receiving generically written prescriptions should be reviewed with a view to change the prescribing to a cost-effective brand.
Longtec (oxycodone MR) and Shortec (oxycodone immediate release) are recommended as the preferred cost-effective brand of oxycodone for Surrey Downs CCG.
Oxycodone is recommended as GREEN (not 1st line), strong opioid, after morphine, on the traffic light system.
See SDCCG Policy statement at bottom of page
The PCN recommends the branded prescribing of oxycodone in line with advice from the Care Quality Commission (CQC). Care Quality Commission link to guidance below. The current (February 2017), most cost effective brands of oxycodone are:
- Modified release: Longtec & Reltebon
- Immediate release: Shortec & Lynlor
CCGs to implement guidance, if considered appropriate, in collaboration with local stakeholders. See individual CCG recommendation documents (at the bottom of the page) where local agreements have been reached. Oxycodone is recommended as GREEN (not 1st line), strong opioid, after morphine, on the traffic light system.